Apogee Therapeutics, Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$47.21(as of Oct 8, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Apogee Therapeutics, Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$47.21
Ticker SymbolAPGE
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees196
CountyUSA
Market Cap$2,367.8M
EBIDTA-270.1M
10-Day Moving Average39.21
P/E Ratio-9.77
20-Day Moving Average38.31
Forward P/E Ratio0.00
50-Day Moving Average37.65
Earnings per Share-4.14
200-Day Moving Average38.69
Profit Margin-Infinity%
RSI58.33
Shares Outstanding46.1M
ATR1.54
52-Week High63.50
Volume495,197
52-Week Low26.20
Most Recent Support Level39.21
Book Value619.4M
Most Recent Resistance Level40.48
P/B Ratio3.75
Upper Keltner41.78
P/S Ratio17,856.60
Lower Keltner34.84
Debt-to-Equity Ratio41.78
Next Earnings Date11/18/2025
Cash Surplus92.6M
Next Ex-Dividend DateUnknown

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical trial. It also develops APG279 that is in preclinical stage for the treatment of AD; APG990, an SQ extended half-life mAb for the treatment of AD; APG333, a human mAb against thymic stromal lymphopoietin for the treatment of asthma and COPD; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Apogee Therapeutics, Inc. Common Stock In Our Stock Scanner

As of Oct 09, 2025
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.